Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Finger

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Medicinal Chemistry|July 8, 2023
2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1Vladimir Finger, Tomas Kucera, Radka Kafkova, et al.
European Journal of Medicinal Chemistry|April 27, 2025
Novel tacrine-based multi-target directed Ligands: Enhancing cholinesterase inhibition, NMDA receptor antagonism, and CNS bioavailability for Alzheimer's disease treatmentBarbora Svobodova, Zuzana Moravcova, Anna Misiachna, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 13, 2025
Novel antitubercular agents based on 2,4-disubstituted 5-(aryl-2-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidinesVladimir Finger, Martin Vrbicky, Lubica Muckova, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Medicinal Chemistry|July 8, 2023
2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1Vladimir Finger, Tomas Kucera, Radka Kafkova, et al.
European Journal of Medicinal Chemistry|April 27, 2025
Novel tacrine-based multi-target directed Ligands: Enhancing cholinesterase inhibition, NMDA receptor antagonism, and CNS bioavailability for Alzheimer's disease treatmentBarbora Svobodova, Zuzana Moravcova, Anna Misiachna, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 13, 2025
Novel antitubercular agents based on 2,4-disubstituted 5-(aryl-2-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidinesVladimir Finger, Martin Vrbicky, Lubica Muckova, et al.
Pageof 2